262 related articles for article (PubMed ID: 15745760)
1. Pharmaceutical companies and ophthalmic research.
Liesegang TJ; Schachat AP; Albert DA
Ophthalmology; 2005 Mar; 112(3):363-5. PubMed ID: 15745760
[No Abstract] [Full Text] [Related]
2. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
Peppercorn J; Blood E; Winer E; Partridge A
Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
[TBL] [Abstract][Full Text] [Related]
3. What should be done to improve the productivity of neurological research?
Moses H; Martin JB
Ann Neurol; 2006 Dec; 60(6):647-51. PubMed ID: 17192925
[No Abstract] [Full Text] [Related]
4. Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics.
Fitzgerald GA
Nat Rev Drug Discov; 2005 Oct; 4(10):815-8. PubMed ID: 16224453
[TBL] [Abstract][Full Text] [Related]
5. In the dark: drug companies should be forced to publish all the results of clinical trials.
Chalmers I
New Sci; 2004 Mar 6-12; 181(2437):19. PubMed ID: 15139350
[No Abstract] [Full Text] [Related]
6. Scripps Florida.
Sheppard TL
Nat Chem Biol; 2007 Aug; 3(8):451. PubMed ID: 17637772
[TBL] [Abstract][Full Text] [Related]
7. [France, an attractive country for international clinical research: 2008 survey assessed by Leem (French association of pharmaceutical companies)].
Lassale C; Sibenaler C; Béhier JM; Plétan Y; Courcier S;
Therapie; 2008; 63(5):345-57. PubMed ID: 19154705
[TBL] [Abstract][Full Text] [Related]
8. ER: the gateway for neurologic emergency trials?
Ann Neurol; 2006 Dec; 60(6):A12-4. PubMed ID: 17192940
[No Abstract] [Full Text] [Related]
9. Sharing pharma compounds with academia: experiences with providing vitamin D receptor ligands.
Schmitz AA; Hackethal S; Schulz A; May E; Steinmeyer A; Zügel U; Asadullah K
Nat Rev Drug Discov; 2015 Apr; 14(4):294. PubMed ID: 25743082
[No Abstract] [Full Text] [Related]
10. Explosion of ophthalmic collaborative research networks in Australia.
Hewitt AW; Yazar S; Franchina M
Clin Exp Ophthalmol; 2013 Apr; 41(3):310-1. PubMed ID: 22957512
[No Abstract] [Full Text] [Related]
11. Big Pharma's Commedia.
Steele FR
Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
[No Abstract] [Full Text] [Related]
12. Industry support for medical centers grows.
Dove A
Nat Med; 2000 Sep; 6(9):948. PubMed ID: 10973295
[No Abstract] [Full Text] [Related]
13. The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
Vallance P; Williams P; Dollery C
Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455
[No Abstract] [Full Text] [Related]
14. Ophthalmic research in Australasia.
Casson RJ; Al-Qureshi S; Vukicevic M
Clin Exp Ophthalmol; 2012; 40(1):1-2. PubMed ID: 22304023
[No Abstract] [Full Text] [Related]
15. The changing roles of industry and academia.
Bauer EA; Cohen DE
J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
[TBL] [Abstract][Full Text] [Related]
16. EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunities.
Couvreur P; Barguer D; Crommelin DJ; Duchêne D; Engels JW; Kerr DJ; Krogsgaard-Larsen P; Meijer DK; Paoletti R; Wagner E;
Eur J Pharm Sci; 2005 Feb; 24(2-3):245-52. PubMed ID: 15776539
[No Abstract] [Full Text] [Related]
17. Ethics and industry-sponsored research.
Koehler B
CMAJ; 2002 Mar; 166(5):581; author reply 582. PubMed ID: 11898935
[No Abstract] [Full Text] [Related]
18. Urological research within the pharmaceutical industry: back to basics?
Wyllie MG
BJU Int; 2004 Jun; 93(9):1349-50. PubMed ID: 15180636
[No Abstract] [Full Text] [Related]
19. Aligning pharmaceutical innovation with medical need.
Nathan C
Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
[No Abstract] [Full Text] [Related]
20. Expanding access to published research: open access and self-archiving.
Mower A; Youngkin ME
J Neuroophthalmol; 2008 Mar; 28(1):69-71. PubMed ID: 18347463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
